Inventor · disambiguated record
Yixin Ai
Also filed as: AI YIXIN
7 granted patents·2 pending applications·7 citations·filing 2018–2023
74Inventor score
Files withSHENZHEN TARGETRX INC9
Top patents by PatentIndex Score
9 records- 0188US11319317B2(Hetero)arylamide compound for inhibiting protein kinase activitySHENZHEN TARGETRX INC·Filed 2020·Granted May 3, 2022·2 cites·18 claims
- 0281US10875853B2(Hetero)arylamide compound for inhibiting protein kinase activitySHENZHEN TARGETRX INC·Filed 2018·Granted Dec 29, 2020·3 cites·8 claims
- 0375US11091462B2(Hetero)arylamide compound for inhibiting protein kinase activitySHENZHEN TARGETRX INC·Filed 2018·Granted Aug 17, 2021·2 cites·17 claims
- 0461US2025179027A1Cycloalkyl or heterocyclyl substituted heteroaryl compound, and composition and use thereofSHENZHEN TARGETRX INC·Filed 2023·Application pending·0 cites
- 0556US2022380375A1Substituted aromatic fused ring derivative and composition comprising same, and use thereofSHENZHEN TARGETRX INC·Filed 2022·Application pending·0 cites
- 0649US12365685B2Substituted fused aromatic ring derivative, composition and use thereofSHENZHEN TARGETRX INC·Filed 2020·Granted Jul 22, 2025·0 cites·12 claims
- 0749US11111233B2Amino pyrimidine compound for inhibiting protein tyrosine kinase activitySHENZHEN TARGETRX INC·Filed 2019·Granted Sep 7, 2021·0 cites·11 claims
- 0846US11358973B2Di(hetero)aryl macrocyclic compound for inhibiting protein kinase activitySHENZHEN TARGETRX INC·Filed 2019·Granted Jun 14, 2022·0 cites·12 claims
- 0944US11746110B2Alkynyl (hetero) aromatic ring compounds used for inhibiting protein kinase activitySHENZHEN TARGETRX INC·Filed 2019·Granted Sep 5, 2023·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →